M. Pauskar

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Stable level of HIV transmitted drug resistance in Estonia despite significant scale-up of antiretroviral therapy.

K. Van Laethem, E. Kallas, R. Avi, 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Risk factors associated with gut and nasopharyngeal colonization by common Gram-negative species and yeasts in neonatal intensive care units patients.

T. Metsvaht, I. Lutsar, E. Sepp, 2011, Early human development.

Prevalence and genotypes of GBV‐C and its associations with HIV infection among persons who inject drugs in Eastern Europe

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2017, Journal of medical virology.

Association of IFNλ4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2018, Journal of medical virology.

A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs

A. Uusküla, E. Kallas, K. Rüütel, 2016, PloS one.

CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users

A. Uusküla, K. Rüütel, R. Avi, 2013, PloS one.

Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Human T-Lymphotropic Virus Types 1 and 2 Are Rare Among Persons who inject drugs in Eastern Europe

Jarlais, A. Uusküla, E. Kallas, 2016 .

Group A rotavirus genotypes circulating prior to implementation of a National Immunization Program in Estonia

H. Soeorg, K. Huik, I. Lutsar, 2012, Human vaccines & immunotherapeutics.

Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug users.

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Emerging transmitted drug resistance in treatment-naïve human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia

R. Avi, K. Huik, I. Lutsar, 2011, Scandinavian journal of infectious diseases.

The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx

E. Kallas, R. Avi, K. Huik, 2019, PloS one.

SARS-CoV-2 dual infection with Delta and Omicron variants in an immunocompetent host: a case report

M. Nelis, K. Huik, T. Reisberg, 2022, International Journal of Infectious Diseases.

Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010.

E. Kallas, R. Avi, K. Huik, 2014, AIDS research and human retroviruses.

Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs

D. D. Des Jarlais, A. Uusküla, E. Kallas, 2016, Medical Microbiology and Immunology.

T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use.

A. Uusküla, R. Avi, K. Huik, 2016, Viral immunology.

Full-length genome sequences of Estonian HIV-1 CRF06 and Eastern-European subtype A1 recombinant forms

R. Avi, K. Huik, I. Lutsar, 2014, BMC Infectious Diseases.